Jen Monnier is an intern at Spectrum. She is a journalist in New York City, covering medicine, technology and ecosystems. She’s also a graduate student at New York University’s Science, Health and Environmental Reporting program.
Jen Monnier
From this contributor
Early interventions, explained
The accepted wisdom in autism research holds that early intervention offers the best promise for an autistic child’s well-being. But how effective are these therapies?
Multipart device monitors various senses in babies
A new assemblage of tools precisely gauges a baby’s biological response to sights, sounds and tactile stimuli all at once.
Multipart device monitors various senses in babies
New consortium may create projects, funding for autism research
A newly formed group of leaders from the U.S. National Institutes of Health (NIH) is poised to generate funding opportunities for child health research, including autism science.
New consortium may create projects, funding for autism research
Glowing capsule illuminates problems in gut
An ingestible electronic capsule enables researchers to instantaneously detect molecules associated with gastrointestinal issues.
Explore more from The Transmitter
How to teach programming in the age of AI
Scientists and educators are concerned about students using artificial intelligence to shortcut their learning. But there are also opportunities, especially when it comes to teaching neuroscience students how to code.
How to teach programming in the age of AI
Scientists and educators are concerned about students using artificial intelligence to shortcut their learning. But there are also opportunities, especially when it comes to teaching neuroscience students how to code.
Neuroscience conference policy draws confusion, apology
NeurIPS organizers apologized and altered course after issuing a policy that barred submissions from researchers at U.S.-government-sanctioned institutions.
Neuroscience conference policy draws confusion, apology
NeurIPS organizers apologized and altered course after issuing a policy that barred submissions from researchers at U.S.-government-sanctioned institutions.
Funding for animal research alternatives reaches ‘inflection point’
The United States and Europe are dedicating hundreds of millions of dollars in funding to advance novel alternative methods, but not all neuroscientists see this as a positive step.
Funding for animal research alternatives reaches ‘inflection point’
The United States and Europe are dedicating hundreds of millions of dollars in funding to advance novel alternative methods, but not all neuroscientists see this as a positive step.